NYSE:CLB

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. More Details


Snowflake Analysis

Reasonable growth potential with imperfect balance sheet.


Similar Companies

Share Price & News

How has Core Laboratories's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: CLB is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: CLB's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.


Market Performance


7 Day Return

10.7%

CLB

9.0%

US Energy Services

1.5%

US Market


1 Year Return

-42.2%

CLB

-29.7%

US Energy Services

22.3%

US Market

Return vs Industry: CLB underperformed the US Energy Services industry which returned -32% over the past year.

Return vs Market: CLB underperformed the US Market which returned 22.1% over the past year.


Shareholder returns

CLBIndustryMarket
7 Day10.7%9.0%1.5%
30 Day76.2%49.6%8.8%
90 Day27.9%29.0%10.8%
1 Year-41.8%-42.2%-27.7%-29.7%25.1%22.3%
3 Year-71.8%-73.6%-54.4%-58.0%49.5%39.6%
5 Year-73.5%-76.2%-53.0%-61.2%105.8%83.3%

Long-Term Price Volatility Vs. Market

How volatile is Core Laboratories's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Core Laboratories undervalued compared to its fair value and its price relative to the market?

10.5%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: CLB ($26.67) is trading below our estimate of fair value ($29.78)

Significantly Below Fair Value: CLB is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: CLB is unprofitable, so we can't compare its PE Ratio to the US Energy Services industry average.

PE vs Market: CLB is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate CLB's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: CLB is overvalued based on its PB Ratio (17.5x) compared to the US Energy Services industry average (0.6x).


Next Steps

Future Growth

How is Core Laboratories forecast to perform in the next 1 to 3 years based on estimates from 13 analysts?

66.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CLB is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.2%).

Earnings vs Market: CLB is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: CLB's is expected to become profitable in the next 3 years.

Revenue vs Market: CLB's revenue (6.7% per year) is forecast to grow slower than the US market (10.2% per year).

High Growth Revenue: CLB's revenue (6.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: CLB's Return on Equity is forecast to be high in 3 years time (34.9%)


Next Steps

Past Performance

How has Core Laboratories performed over the past 5 years?

-30.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: CLB is currently unprofitable.

Growing Profit Margin: CLB is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: CLB is unprofitable, and losses have increased over the past 5 years at a rate of 30% per year.

Accelerating Growth: Unable to compare CLB's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CLB is unprofitable, making it difficult to compare its past year earnings growth to the Energy Services industry (-34.7%).


Return on Equity

High ROE: CLB has a negative Return on Equity (-140.47%), as it is currently unprofitable.


Next Steps

Financial Health

How is Core Laboratories's financial position?


Financial Position Analysis

Short Term Liabilities: CLB's short term assets ($169.9M) do not cover its short term liabilities ($172.1M).

Long Term Liabilities: CLB's short term assets ($169.9M) do not cover its long term liabilities ($347.0M).


Debt to Equity History and Analysis

Debt Level: CLB's debt to equity ratio (373.4%) is considered high.

Reducing Debt: CLB had negative shareholder equity 5 years ago, but is now positive and has therefore improved.

Debt Coverage: CLB's debt is well covered by operating cash flow (34%).

Interest Coverage: CLB is unprofitable, therefore interest payments are not well covered by earnings.


Balance Sheet


Next Steps

Dividend

What is Core Laboratories's current dividend yield, its reliability and sustainability?

0.15%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: CLB's dividend (0.15%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.49%).

High Dividend: CLB's dividend (0.15%) is low compared to the top 25% of dividend payers in the US market (4.1%).


Stability and Growth of Payments

Stable Dividend: CLB is not paying a notable dividend for the US market, therefore no need to check if payments are stable.

Growing Dividend: CLB is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: CLB is not paying a notable dividend for the US market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of CLB's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.5yrs

Average management tenure


CEO

Larry Bruno (60 yo)

0.58

Tenure

US$2,969,162

Compensation

Mr. Lawrence V. Bruno, also known as Larry, serves as Chairman of Supervisory Board and Chief Exertive Officer at Core Laboratories N.V. since May 20, 2020. He has been Supervisory Director of Core Laborat...


CEO Compensation Analysis

Compensation vs Market: Larry's total compensation ($USD2.97M) is about average for companies of similar size in the US market ($USD2.60M).

Compensation vs Earnings: Larry's compensation has increased whilst the company is unprofitable.


Leadership Team

NamePositionTenureCompensationOwnership
Lawrence Bruno
Chairman of the Board0.58yrUS$2.97m0.024%
$ 289.7k
Christopher Hill
Senior VP & CFO2.58yrsUS$1.09m0.034%
$ 404.5k
David Demshur
Executive Officer0.58yrUS$11.18m1.56%
$ 18.5m
Kevin Daniels
Chief Accounting Officer2.5yrsno data0.0018%
$ 21.0k
Gwendolyn Schreffler
Senior Vice President of Corporate Development & Investor Relations4.33yrsno datano data
Mark Elvig
Senior VP12.75yrsno data0.071%
$ 842.2k
Jacobus Schouten
Managing Directorno dataUS$174.34kno data
J. Dumas
Senior VP of Production Enhancement & Business Development0.92yrno datano data

2.5yrs

Average Tenure

60.5yo

Average Age

Experienced Management: CLB's management team is considered experienced (2.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Lawrence Bruno
Chairman of the Board0.58yrUS$2.97m0.024%
$ 289.7k
Harvey Klingensmith
Independent Supervisory Director0.58yrno data0.0045%
$ 53.3k
Michael Straughen
Independent Supervisory Director4.92yrsUS$258.14k0.0077%
$ 91.3k
Martha Carnes
Lead Independent Director0.58yrUS$258.21k0.014%
$ 169.8k
Margaret van Kempen
Independent Supervisory Director8.58yrsUS$236.34k0.012%
$ 146.6k
Gregory Barnett
Independent Supervisory Director1.58yrsUS$119.14k0.034%
$ 404.4k
Monique G. van Dijken Eeuwijk
Independent Supervisory Director0.58yrno datano data

0.6yrs

Average Tenure

60yo

Average Age

Experienced Board: CLB's board of directors are not considered experienced ( 0.6 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Core Laboratories N.V.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Core Laboratories N.V.
  • Ticker: CLB
  • Exchange: NYSE
  • Founded: 1936
  • Industry: Oil and Gas Equipment and Services
  • Sector: Energy
  • Market Cap: US$1.187b
  • Shares outstanding: 44.49m
  • Website: https://www.corelab.com

Number of Employees


Location

  • Core Laboratories N.V.
  • Tower A
  • Level 9
  • Amsterdam
  • Noord-Holland
  • 1077 XX
  • Netherlands

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CLBNYSE (New York Stock Exchange)YesCommon SharesUSUSDSep 1995
CEIDB (Deutsche Boerse AG)YesCommon SharesDEEURSep 1995
CLBENXTAM (Euronext Amsterdam)YesCommon SharesNLEURSep 1995
0Q82LSE (London Stock Exchange)YesCommon SharesGBEURSep 1995
CLBABATS-CHIXE (BATS 'Chi-X Europe')YesCommon SharesGBEURSep 1995
CLB NBMV (Bolsa Mexicana de Valores)YesCommon SharesMXMXNSep 1995

Biography

Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/12/05 00:33
End of Day Share Price2020/12/04 00:00
Earnings2020/09/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.